Erratum: Treating depressed children with antidepressants: More harm than benefit? (Journal of Clinical Psychology in Medical Settings (2008) vol. 15 (92-97) 10.1007/s10880-008-9108-9);Treating depressed children with antidepressants: More harm than benefit?

Journal of Clinical Psychology in Medical Settings

Volumn 15, Issue 2, 2008, Pages 92-97

  Antonuccio, David ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Children; Depression

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; BEHAVIOR THERAPY; CHILD CARE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HUMAN; INSOMNIA; MANIA; MOOD DISORDER; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGIST; PSYCHOSOCIAL CARE; RESTLESSNESS; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SLEEP DISORDER; SOMNOLENCE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME; UNITED STATES; WORKSHOP;

EID: 45449094378     PISSN: 10689583     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10880-008-9121-z     Document Type: Erratum

References (52)

1. Ambrosini, P. J., Bianchi, M. D., Rabinovich, H., & Elia, J. (1993). Antidepressant treatment in children and adolescents: I. Affective Disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1-6.
2. American Psychiatric Association. (2005). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Antonuccio, D. O. (in press). Tailoring treatment to parental values: A comment on TADS. Archives of General Psychiatry.
4. Antonuccio, D. O. (2007). Antidepressants in children: More harm than benefit? Paper presented at the annual meeting of the American Psychological Association, San Francisco.
5. Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R. P., & Gordon, J. S. (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68, 3-14.
6. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297, 1683-1696.
7. Brown, R., Antonuccio, D. O., DuPaul, G., Fristad, M., King, C., Pelham, W., et al. (2006). Psychopharmacological, psychosocial, and combined interventions for childhood disorders: Evidence base, contextual, factors, and future directions. Report of the Working Group on Psychoactive Medications for Children and Adolescents, American Psychological Association.
8. Brown, R., Antonuccio, D. O., DuPaul, G., Fristad, M., King, C., Pelham, W., et al. (2007). Childhood mental health disorders: Evidence base and contextual factors for psychosocial, psychopharmacological, and combined interventions. Washington, DC: American Psychological Association.
9. Burns, D. D. (1999). Feeling good: The new mood therapy. New York: HarperCollins.
10. Clarke, G., Lewinsohn, P., & Hops, H. (1990). Adolescent coping with depression course. Eugene, Oregon: Castalia Publishing Company.
11. Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996). Serotonin reuptake inhibitor withdrawal. Journal of Clinical Psychopharmacology, 16, 356-362.
12. Csoka, A. B., & Shipko, S. (2006) Persistant sexual side effects after SSRI discontinuation. Psychotherapy and Psychosomatics, 75, 187-188.
13. Dalfen, A. K., & Stewart, D. E. (2001). Who develops stable or fatal adverse drug reactions to selective serotonin reuptake inhibitors? Canadian Journal of Psychiatry, 46, 258-262.
14. Donovan, S., Madeley, R., Clayton, A., Beeharry, M., Jones, S., Kirk, C., et al. (2000). Deliberate self-harm and antidepressant drugs: Investigation of a possible link. British Journal of Psychiatry, 177, 551-556.
15. Duvjone, V. F., Barnard, M. U., & Rapoff, M. A. (1995). Pharmacological and cognitive-behavioral approaches in the treatment of childhood depression: A review and critique. Clinical Psychology Review, 15, 589-611.
16. Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., Hoog, S. L., Ernest, D. E., Brown, E., et al. (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205-1215.
17. Emslie, G. J., Rush, J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
18. Fava, G. A. (2002). Long-term treatment with antidepressant drugs: The spectacular achievements of propaganda. Psychotherapy and Psychosomatics, 71, 127-132.
19. Fisher, R. L., & Fisher, S. (1996). Antidepressants for children: Is scientific support necessary? The Journal of Nervous and Mental Disease, 184, 99-102.
20. Garland, E. J. (2004). Facing the evidence: Antidepressant treatment in children and adolescents. Canadian Medical Association Journal, 170, 489-491.
21. Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry, 163, 1898-1904.
22. Goode, E. (2004) Stronger warnings urged on antidepressants for teenagers, February 3, 2004, New York Times.
23. Hammad, T. A., Laughren, T., & Racoosin (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
24. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. British Medical Journal, 310, 897-901.
25. Healy, D. (2003). Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics, 72, 71-79.
26. Healy, D. (2006). The latest mania: Selling bipolar disorder. PLoS Medicine, 3, e185. Accessed at www.plosmedicine.org.
27. Jureidini, J. N., Doecke, C. J., Mansfield, P. R., Haby, M. M., Menkes, D. B., & Tonkin, A. L. (2004), Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879-883.
28. Keller, M., Ryan, N., Strober, M., Klein, R., Kutcher, S., Birmaher, B., et al. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762-772.
29. Kendall, T., Pilling, S., & Whittington, C. J. (2005). Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Current Opinions in Psychiatry, 18, 21-25.
30. Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, 260-268.
31. Kuehn, B. M. (2007). Cognitive behavioral therapy shows promise for children with mental illness. Journal of the American Medical Association, 297, 453-455.
32. Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Medicine 2, e392 doi: 10.1371/journal.pmed.0020392.
33. Lancet (2004). Depressing Research, 363, 1335.
34. Laughren, T. P. (2004). Background comments for February 2, 2004 Meeting of Psychopharmacological Drugs Advisory Committee (PDAC) and Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee (Peds AC). Memo from Dept. of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research. Retrieved June 21, 2005 from http://www.fda.gov/ohrms/dockets/ac/04/ briefing/4006B1_03_Background_Memo_01-05-04.htm.
35. Lineberry, T. W., Bostwick, J. M., Beebe, T. J., & Decker, P. A. (2007). Impact of the FDA black box warning on physician antidepessant prescribing and practice patterns: Opening Pandora's suicide box. Mayo Clinic Proceedings, 82, 516-522. Retrieved at http://www.mayoclinicproceedings.com/inside.asp?AID=4346&UID=.
36. Michael, K. D., & Crowley, S. L. (2002). How effective are treatments for children and adolescent depression? A meta-analytic review. Clinical Psychology Review, 22, 247-269.
37. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National Trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64, 1032-1039.
38. National Center for Health Statistics (2004). Health, United States, 2004. Hyattsville, Maryland.
39. Preda, A., MacLean, R. W., Mazure, C. M., & Bowers, M. B. (2001). Antidepressant-associated mania and psychosis resulting in psychiatric admissions. Journal of Clinical Psychiatry, 62, 30-33.
40. Rigoni, G. (2004, February 2). Drug utilization for selected antidepressants among children and adolescents in the U.S. In Psychopharmacologic Drugs Advisory Committee and Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee. Retrieved on April 22, 2005 from http://www.fda.gov/ohrms/dockets/ac/04/slides040061.htm.
41. Rosenbaum, J. F., Fava, M., Hood, S. L., Ashcroft, R. C., & Krebs, W. B. (1998). Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial. Biological Psychiatry, 44, 77-87.
42. Seligman, M. E. P., Reivich, M. A., Jaycox, L., & Gillham, J. (1995). The optimistic child. Boston, MA: Houghton Mifflin.
43. Simeon, J., Dinicola, V., Ferguson, B., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-psychopharmacology and Biological Psychiatry, 14, 791-795.
44. Sommers-Flanagan, J., & Sommers-Flanagan, R. (1996). Efficacy of antidepressant medication with depressed youth: What psychologists should know. Professional Psychology: Research and Practice, 27, 145-153.
45. Treatment for Adolescent Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Treatment for Adolescents of Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807-820.
46. Treatment for Adolescents with Depression Study (TADS) Team. (2007). Treatment for adolescents with depression study: Long term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132-1144.
47. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 252-260.
48. U.S. Department of Health and Human Services. (2004). NTP-CERHR expert panel report on the reproductive and developmental toxicity of fluoxetine. Center for the evaluation of risks to human reproduction. National Toxicology Program. NTP-CERHR-Fluoxetine.
49. Wagner, K., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M., et al. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Journal of the American Medical Association, 290, 1033-1041.
50. Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M., & Heydon, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161, 1079-1083.
51. Weintrob, N., Cohen, D., Klipper-Aurbach, Y., Zadik, Z., & Dickerman, Z. (2002). Decreased growth during therapy with selective serotonin reuptake inhibitors. Archives of Pediatric and Adolescent Medicine, 156, 696-791.
52. Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. The Lancet, 363, 1341-1345.